FDA News

FDA committee unanimously recommends approval of teprotumumab for thyroid eye disease

December 13, 2019
The Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA voted 12-0 Friday in favor of recommending approval of a biologics license…

In the Journals

Associations urge caution after controversial radioactive iodine findings

December 12, 2019
The Society for Endocrinology and the British Thyroid Association issued a joint statement urging caution when interpreting a recent study linking…

Feature

Future of thyroid nodule classification driven by AI, machine learning as support tools

December 12, 2019
The detection and diagnosis of thyroid nodules may be on the cusp of a technological overhaul as a growing body of research on artificial…

In the Journals

Hypothyroidism raises mortality risk among older adults

December 12, 2019
Older adults with hypothyroidism are 26% more likely to die of any cause when compared with euthyroid older adults, although secondary analyses…

FDA News

Recent FDA actions you may have missed

December 1, 2019
Endocrine Today has compiled a list of recent FDA news stories relating to endocrine practice. Drugs under consideration included those for thyroid…

Endocrine Today expert interviews

November 30, 2019
Each month Endocrine Today reporters ask leading endocrinologists and diabetes educators about their resesarch and practices. Some of our recent…

In the Journals

Survey reflects ‘empathy gap’ in management of hypoparathyroidism

November 25, 2019
Adults with inadequately controlled hypoparathyroidism reported substantial symptoms related to the disease and health-related quality of life, with…

Meeting News

‘Stay tuned:’ Neoadjuvant therapy in thyroid cancer still needs research

November 19, 2019
CHICAGO — There are many targeted agents being tested in the neoadjuvant setting for thyroid cancer, however, it is important to understand the…

In the Journals

Thyroid screening unnecessary when symptoms not present: Canadian task force

November 19, 2019
Adults who do not display symptoms of thyroid dysfunction should not be screened for such conditions, according to a recommendation statement from…

NIH selects five Lasker Clinical Research Scholars

November 16, 2019
The NIH selected five scientists as Lasker Clinical Research Scholars. The competitive program — part of a joint initiative with Albert and…

In the Journals

Levothyroxine neutral for bone health in subclinical hypothyroidism

November 15, 2019
Older adults with subclinical hypothyroidism assigned 1 year of levothyroxine therapy experienced no adverse changes in any bone parameters compared…

Meeting News

Top takeaways from ATA

November 10, 2019
Endocrine Today has compiled a list of the top five news reports posted from the American Thyroid Association Annual Meeting, held from Oct. 30 to…

Breaking News

Experts warn PFAS endocrine-disrupting chemicals may drive obesity, osteoporosis

November 6, 2019
WASHINGTON — A class of endocrine-disrupting chemicals known as PFAS may work as an “environmental trigger” to drive multiple…

Meeting News

Personalized therapy improves anaplastic thyroid cancer outcomes

November 6, 2019
CHICAGO — The era of untreatable anaplastic thyroid cancer is progressively being replaced by highly specific molecularbased personalized…

Meeting News

Research underway on essential genes in medullary thyroid cancer

November 6, 2019
CHICAGO — Investigators from The Ohio State University Comprehensive Cancer Center have initiated research on the proteomic gene alterations in…

Meeting News

ATA: Ethical, surgical, medical guidelines coming for anaplastic thyroid cancer

November 4, 2019
CHICAGO — The American Thyroid Association will publish new guidelines on ethical, surgical and medical considerations for patients with…

Meeting News

‘Rational combination therapies’ stand as the next step in thyroid cancer

November 4, 2019
CHICAGO — Bryan R. Haugen, MD, professor of medicine in the department of medicine-endocrinology, metabolism and diabetes at the University of…

Meeting NewsPerspective

Drug strengths, stability of compounded levothyroxine suspensions vary widely

November 3, 2019
CHICAGO—Compounded oral liquid levothyroxine products vary in stability, potency and consistency and present risks for patients, according to…

Meeting NewsVideo

VIDEO: AI for thyroid images ‘not quite ready’

November 3, 2019
CHICAGO — In this video exclusive, Endocrine Today Editorial Board Member Stephanie L. Lee, MD, PhD, FACE, ECNU, professor of medicine and…

Meeting News

Thyroid function tests frequently yield no evidence of thyroid disease

November 3, 2019
CHICAGO — In a cohort of adults who received a thyroid function test during hospitalization, most did not have a thyroid disease and those who…